Through different pharmacological interventions, i.e., ginsenoside Rb2, erythropoietin, or resveratrol, authors found that AMPK activation and increased levels of SIRT1 both increase autophagic flux and reduce steatosis. The gene discussed is SIRT1; the disease is steatosis.